Literature DB >> 22351489

A dimensional approach to understanding severity estimates and risk correlates of marijuana abuse and dependence in adults.

Li-Tzy Wu1, George E Woody, Chongming Yang, Jeng-Jong Pan, Bryce B Reeve, Dan G Blazer.   

Abstract

While item response theory (IRT) research shows a latent severity trait underlying response patterns of substance abuse and dependence symptoms, little is known about IRT-based severity estimates in relation to clinically relevant measures. In response to increased prevalences of marijuana-related treatment admissions, an elevated level of marijuana potency, and the debate on medical marijuana use, we applied dimensional approaches to understand IRT-based severity estimates for marijuana use disorders (MUDs) and their correlates while simultaneously considering gender- and race/ethnicity-related differential item functioning (DIF). Using adult data from the 2008 National Survey on Drug Use and Health (N = 37,897), Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for MUDs among past-year marijuana users were examined by IRT, logistic regression, and multiple indicators-multiple causes (MIMIC) approaches. Among 6917 marijuana users, 15% met criteria for a MUD; another 24% exhibited subthreshold dependence. Abuse criteria were highly correlated with dependence criteria (correlation = 0.90), indicating unidimensionality; item information curves revealed redundancy in multiple criteria. MIMIC analyses showed that MUD criteria were positively associated with weekly marijuana use, early marijuana use, other substance use disorders, substance abuse treatment, and serious psychological distress. African Americans and Hispanics showed higher levels of MUDs than Whites, even after adjusting for race/ethnicity-related DIF. The redundancy in multiple criteria suggests an opportunity to improve efficiency in measuring symptom-level manifestations by removing low-informative criteria. Elevated rates of MUDs among African Americans and Hispanics require research to elucidate risk factors and improve assessments of MUDs for different racial/ethnic groups.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22351489      PMCID: PMC3370135          DOI: 10.1002/mpr.1354

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  42 in total

1.  An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study.

Authors:  Li-Tzy Wu; Jeng-Jong Pan; Dan G Blazer; Betty Tai; Maxine L Stitzer; Robert K Brooner; George E Woody; Ashwin A Patkar; Jack D Blaine
Journal:  J Stud Alcohol Drugs       Date:  2009-05       Impact factor: 2.582

2.  Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study.

Authors:  Li-Tzy Wu; Jeng-Jong Pan; Dan G Blazer; Betty Tai; Maxine L Stitzer; George E Woody
Journal:  J Subst Abuse Treat       Date:  2010-06

3.  The predictors of self-rated health and the relationship between self-rated health and health service needs are similar across socioeconomic groups in Canada.

Authors:  Peter M Smith; Richard H Glazier; Lyn M Sibley
Journal:  J Clin Epidemiol       Date:  2009-11-17       Impact factor: 6.437

4.  The epidemiology of substance use and disorders among middle aged and elderly community adults: national survey on drug use and health.

Authors:  Dan G Blazer; Li-Tzy Wu
Journal:  Am J Geriatr Psychiatry       Date:  2009-03       Impact factor: 4.105

5.  'Diagnostic orphans' among young adult cannabis users: persons who report dependence symptoms but do not meet diagnostic criteria.

Authors:  Louisa Degenhardt; Michael Lynskey; Carolyn Coffey; George Patton
Journal:  Drug Alcohol Depend       Date:  2002-07-01       Impact factor: 4.492

6.  The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study.

Authors:  Li-Tzy Wu; Jeng-Jong Pan; Dan G Blazer; Betty Tai; Robert K Brooner; Maxine L Stitzer; Ashwin A Patkar; Jack D Blaine
Journal:  Drug Alcohol Depend       Date:  2009-05-06       Impact factor: 4.492

7.  An item response theory analysis of DSM-IV criteria for hallucinogen abuse and dependence in adolescents.

Authors:  Li-Tzy Wu; Jeng-Jong Pan; Chongming Yang; Bryce B Reeve; Dan G Blazer
Journal:  Addict Behav       Date:  2009-10-22       Impact factor: 3.913

8.  Construct and differential item functioning in the assessment of prescription opioid use disorders among American adolescents.

Authors:  Li-Tzy Wu; Christopher L Ringwalt; Chongming Yang; Bryce B Reeve; Jeng-Jong Pan; Dan G Blazer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-05       Impact factor: 8.829

9.  Hallucinogen use disorders among adult users of MDMA and other hallucinogens.

Authors:  Li-Tzy Wu; Christopher L Ringwalt; Paolo Mannelli; Ashwin A Patkar
Journal:  Am J Addict       Date:  2008 Sep-Oct

10.  The role of cannabis use within a dimensional approach to cannabis use disorders.

Authors:  Wilson M Compton; Tulshi D Saha; Kevin P Conway; Bridget F Grant
Journal:  Drug Alcohol Depend       Date:  2008-12-04       Impact factor: 4.492

View more
  10 in total

1.  Marijuana use disorder symptoms among recent onset marijuana users.

Authors:  Lisa Dierker; William Mendoza; Renee Goodwin; Arielle Selya; Jennifer Rose
Journal:  Addict Behav       Date:  2017-01-06       Impact factor: 3.913

2.  Cannabis problem experiences among users of the tobacco-cannabis combination known as blunts.

Authors:  Brian J Fairman
Journal:  Drug Alcohol Depend       Date:  2015-02-23       Impact factor: 4.492

Review 3.  DSM-5 criteria for substance use disorders: recommendations and rationale.

Authors:  Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant
Journal:  Am J Psychiatry       Date:  2013-08       Impact factor: 18.112

4.  DSM-5 cannabis use disorder: a phenotypic and genomic perspective.

Authors:  Arpana Agrawal; Michael T Lynskey; Kathleen K Bucholz; Manav Kapoor; Laura Almasy; Danielle M Dick; Howard J Edenberg; Tatiana Foroud; Alison Goate; Dana B Hancock; Sarah Hartz; Eric O Johnson; Victor Hesselbrock; John R Kramer; Samuel Kuperman; John I Nurnberger; Marc Schuckit; Laura J Bierut
Journal:  Drug Alcohol Depend       Date:  2013-11-16       Impact factor: 4.492

Review 5.  Review: Prevalence and co-occurrence of addictions in US ethnic/racial groups: Implications for genetic research.

Authors:  Susan E Luczak; Rubin Khoddam; Sheila Yu; Tamara L Wall; Anna Schwartz; Steve Sussman
Journal:  Am J Addict       Date:  2016-10-19

6.  Using electronic health records data to assess comorbidities of substance use and psychiatric diagnoses and treatment settings among adults.

Authors:  Li-Tzy Wu; Kenneth R Gersing; Marvin S Swartz; Bruce Burchett; Ting-Kai Li; Dan G Blazer
Journal:  J Psychiatr Res       Date:  2013-01-19       Impact factor: 4.791

Review 7.  Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects.

Authors:  Dvora Shmulewitz; Emily R Greene; Deborah Hasin
Journal:  Alcohol Clin Exp Res       Date:  2015-09-01       Impact factor: 3.455

8.  Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study.

Authors:  Li-Tzy Wu; Kathleen T Brady; Paolo Mannelli; Therese K Killeen
Journal:  J Psychiatr Res       Date:  2013-12-01       Impact factor: 4.791

9.  Impulsivity, Depressive Mood, and Cannabis Use in a Representative Sample of French-Speaking Swiss Young Men.

Authors:  Lucien Rochat; Olivia Mobbs; Joël Billieux; Yasser Khazaal; Christophe Zufferey
Journal:  Psychol Belg       Date:  2022-07-26

10.  The Treatment Effectiveness Assessment (TEA): an efficient, patient-centered instrument for evaluating progress in recovery from addiction.

Authors:  Walter Ling; David Farabee; Dagmar Liepa; Li-Tzy Wu
Journal:  Subst Abuse Rehabil       Date:  2012-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.